These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng B, Nong S, Qin H. J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390 [Abstract] [Full Text] [Related]
3. LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells. Fan H, Lv P, Mu T, Zhao X, Liu Y, Feng Y, Lv J, Liu M, Tang H. Cancer Lett; 2018 Aug 10; 429():89-99. PubMed ID: 29753758 [Abstract] [Full Text] [Related]
5. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway. Bai PS, Hou P, Kong Y. Exp Cell Res; 2018 Sep 01; 370(1):174-188. PubMed ID: 29928866 [Abstract] [Full Text] [Related]
6. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K. Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020 [Abstract] [Full Text] [Related]
12. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L, Han T, Liu K, Lei CG, Wang ZC, Shi GJ. Eur Rev Med Pharmacol Sci; 2019 Jun 17; 23(12):5392-5401. PubMed ID: 31298392 [Abstract] [Full Text] [Related]
15. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Yang X, Sun L, Wang L, Yao B, Mo H, Yang W. Biomed Pharmacother; 2019 Oct 17; 118():109386. PubMed ID: 31545291 [Abstract] [Full Text] [Related]